{"url":"https://uneyama.hatenadiary.jp/entry/20151014/p4","width":"100%","height":"190","provider_url":"https://hatena.blog","blog_url":"https://uneyama.hatenadiary.jp/","type":"rich","published":"2015-10-14 00:00:03","blog_title":"\u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Funeyama.hatenadiary.jp%2Fentry%2F20151014%2Fp4\" title=\"\u8b66\u544a\u6587\u66f8 - \u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","categories":["FDA"],"image_url":null,"author_name":"uneyama","description":"Byron Kramer, Inc. 9/28/15 http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2015/ucm465597.htm \u98df\u7528\u306b\u8ca9\u58f2\u3055\u308c\u305f\u725b\u306e\u6b8b\u7559\u52d5\u7269\u7528\u533b\u85ac\u54c1\u30d5\u30ed\u30eb\u30d5\u30a7\u30cb\u30b3\u30fc\u30eb\u3001\u30b9\u30eb\u30d5\u30a1\u30e1\u30bf\u30b8\u30f3 Ribon Company, Ltd. 10/5/15 http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2015/ucm465792.htm \u65e5\u672c\u306e\u4f1a\u793e\u3002FDA\u304c\u5c0f\u7267\u5e02\u306e\u65bd\u8a2d\u30922015\u5e742\u670819-20\u65e5\u306b\u67fb\u5bdf\u3057\u3001\u7c73\u56fd\u306b\u8f38\u51fa\u3057\u3066\u3044\u308b\u5317\u6d77\u9053\u30df\u30eb\u30af\u30bd\u30d5\u2026","version":"1.0","provider_name":"Hatena Blog","author_url":"https://blog.hatena.ne.jp/uneyama/","title":"\u8b66\u544a\u6587\u66f8"}